| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 365 | 2024 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 364 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 347 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 249 | 2024 |
| Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study SK Mahil, N Dand, KJ Mason, ZZN Yiu, T Tsakok, F Meynell, B Coker, ... Journal of allergy and clinical immunology 147 (1), 60-71, 2021 | 182 | 2021 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 154 | 2024 |
| Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global … YH Shin, J Hwang, R Kwon, SW Lee, MS Kim, ... Allergy 78 (8), 2232-2254, 2023 | 141 | 2023 |
| Prevalence, severity and clinical features of psoriasis in fingernails and toenails in adult patients: Italian experience V Brazzelli, A Carugno, A Alborghetti, V Grasso, R Cananzi, L Fornara, ... Journal of the European Academy of Dermatology and Venereology 26 (11), 1354 …, 2012 | 126 | 2012 |
| Italian Guidelines in Patch Testing - adapted from the European Society of Contact Dermatitis (ESCD) G Ital Dermatol Venereol 154 (3), 227-253, 2019 | 97* | 2019 |
| Italian Guidelines in diagnosis and treatment of alopecia areata A Rossi, M Muscianese, BM Piraccini, M Starace, M Carlesimo, ... Giornale Italiano di Dermatologia e Venereologia 154 (6), 609-623, 2019 | 85 | 2019 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet 403 (10440), 2057-2099, 2024 | 75 | 2024 |
| Histologic features of long‐lasting chilblain‐like lesions in a paediatric COVID‐19 patient AG Locatelli, ER Test, P Vezzoli, A Carugno, E Moggio, L Consonni, ... Journal of the European Academy of Dermatology and Venereology 34 (8), e365, 2020 | 67 | 2020 |
| Acute generalized exanthematous pustulosis with erythema multiforme‐like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID‐19) ER Test, P Vezzoli, A Carugno, F Raponi, A Gianatti, F Rongioletti, ... Journal of the European Academy of Dermatology and Venereology 34 (9), e457, 2020 | 63 | 2020 |
| No evidence of increased risk for coronavirus disease 2019 (COVID‐19) in patients treated with dupilumab for atopic dermatitis in a high‐epidemic area–Bergamo, Lombardy, Italy A Carugno, F Raponi, AG Locatelli, P Vezzoli, DM Gambini, M Di Mercurio, ... Journal of the European Academy of Dermatology and Venereology 34 (9), e433, 2020 | 58* | 2020 |
| IgA anti‐epidermal transglutaminase autoantibodies: a sensible and sensitive marker for diagnosis of dermatitis herpetiformis in adult patients G Borroni, F Biagi, O Ciocca, C Vassallo, A Carugno, R Cananzi, ... Journal of the European Academy of Dermatology and Venereology 27 (7), 836-841, 2013 | 58 | 2013 |
| Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study M Talamonti, M Galluzzo, A Chiricozzi, P Quaglino, G Fabbrocini, ... Expert Opinion on Biological Therapy 21 (2), 271-277, 2021 | 52 | 2021 |
| Italian guidelines for therapy of atopic dermatitis—Adapted from consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) G Damiani, P Calzavara‐Pinton, L Stingeni, K Hansel, F Cusano, ... Dermatologic Therapy 32 (6), e13121, 2019 | 52 | 2019 |
| COVID-19 and biologics for psoriasis: a high-epidemic area experience—Bergamo, Lombardy, Italy A Carugno, DM Gambini, F Raponi, P Vezzoli, AGC Locatelli, ... Journal of the American Academy of Dermatology 83 (1), 292-294, 2020 | 50 | 2020 |
| A dermatologic assessment of 101 mpox (monkeypox) cases from 13 countries during the 2022 outbreak: Skin lesion morphology, clinical course, and scarring S Prasad, CG Casas, AG Strahan, LC Fuller, K Peebles, A Carugno, ... Journal of the American Academy of Dermatology 88 (5), 1066-1073, 2023 | 49 | 2023 |
| Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: data from the DA‐COVID‐19 registry A Chiricozzi, M Talamonti, C De Simone, M Galluzzo, N Gori, ... Allergy 76 (6), 1813-1824, 2021 | 37 | 2021 |
